Biotechnology (25) | Debenture Agreements (25)
Browse by Company
Recent Contracts
-
Fourth Amendment to $15,000 8% Convertible Debenture, dated October 7, 2021
(Qrons Inc., Filed With SEC on December 1, 2021)
-
Fifth Amendment to $10,000 8% Convertible Debenture, dated October 7, 2021
(Qrons Inc., Filed With SEC on December 1, 2021)
-
The Convertible Debenture
(Q BioMed Inc., Filed With SEC on October 7, 2021)
-
Form of Senior Convertible Debenture
(Inspyr Therapeutics, Inc., Filed With SEC on June 21, 2021)
-
Form of Debenture
(Q BioMed Inc., Filed With SEC on February 16, 2021)
-
Form of Senior Convertible Debenture
(Inspyr Therapeutics, Inc., Filed With SEC on January 12, 2021)
-
Form of Debenture
(Q BioMed Inc., Filed With SEC on December 29, 2020)
-
Form of Senior Convertible Debenture
(Inspyr Therapeutics, Inc., Filed With SEC on October 29, 2020)
-
7% Original Issue Discount Senior Convertible Debenture due August 3, 2021
(VACCINEX, INC., Filed With SEC on August 14, 2020)
-
Form of 7% Original Issue Discount Senior Secured Convertible Debenture due August 3, 2021
(VACCINEX, INC., Filed With SEC on July 31, 2020)
